{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.12.12","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"colab":{"machine_shape":"hm","gpuType":"T4"},"accelerator":"GPU","kaggle":{"accelerator":"nvidiaTeslaT4","dataSources":[],"dockerImageVersionId":31286,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":true}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"markdown","source":"## Local Inference on GPU \nModel page: https://huggingface.co/google/medgemma-1.5-4b-it\n\n‚ö†Ô∏è If the generated code snippets do not work, please open an issue on either the [model repo](https://huggingface.co/google/medgemma-1.5-4b-it)\n\t\t\tand/or on [huggingface.js](https://github.com/huggingface/huggingface.js/blob/main/packages/tasks/src/model-libraries-snippets.ts) üôè","metadata":{}},{"cell_type":"code","source":"# Install required packages\n!pip install -q transformers accelerate\n\n# Login to Hugging Face using Kaggle secrets\nfrom kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\n\ntry:\n    hf_token = user_secrets.get_secret(\"HF_TOKEN\")\n    print(\"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\")\nexcept:\n    print(\"‚ùå Could not get HF_TOKEN - check Secrets panel\")\n    raise\n\nfrom huggingface_hub import login\nlogin(token=hf_token)\n\nprint(\"‚úÖ Logged in to Hugging Face!\")\n\n# Load MedGemma for TEXT-ONLY clinical reasoning\nfrom transformers import AutoTokenizer, AutoModelForCausalLM\nimport torch\n\nprint(\"Loading MedGemma 1.5 4B...\")\n\nmodel_id = \"google/medgemma-1.5-4b-it\"\n\ntokenizer = AutoTokenizer.from_pretrained(model_id, token=hf_token)\nmodel = AutoModelForCausalLM.from_pretrained(\n    model_id,\n    token=hf_token,\n    torch_dtype=torch.bfloat16,\n    device_map=\"auto\"\n)\n\nprint(\"‚úÖ MedGemma loaded successfully!\")# Install required packages\n!pip install -q transformers accelerate\n\n# Login to Hugging Face using Kaggle secrets\nfrom kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\n\ntry:\n    hf_token = user_secrets.get_secret(\"HF_TOKEN\")\n    print(\"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\")\nexcept:\n    print(\"‚ùå Could not get HF_TOKEN - check Secrets panel\")\n    raise\n\nfrom huggingface_hub import login\nlogin(token=hf_token)\n\nprint(\"‚úÖ Logged in to Hugging Face!\")\n\n# Load MedGemma for TEXT-ONLY clinical reasoning\nfrom transformers import AutoTokenizer, AutoModelForCausalLM\nimport torch\n\nprint(\"Loading MedGemma 1.5 4B...\")\n\nmodel_id = \"google/medgemma-1.5-4b-it\"\n\ntokenizer = AutoTokenizer.from_pretrained(model_id, token=hf_token)\nmodel = AutoModelForCausalLM.from_pretrained(\n    model_id,\n    token=hf_token,\n    torch_dtype=torch.bfloat16,\n    device_map=\"auto\"\n)\n\nprint(\"‚úÖ MedGemma loaded successfully!\")# Install required packages\n!pip install -q transformers accelerate\n\n# Login to Hugging Face using Kaggle secrets\nfrom kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\n\ntry:\n    hf_token = user_secrets.get_secret(\"HF_TOKEN\")\n    print(\"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\")\nexcept:\n    print(\"‚ùå Could not get HF_TOKEN - check Secrets panel\")\n    raise\n\nfrom huggingface_hub import login\nlogin(token=hf_token)\n\nprint(\"‚úÖ Logged in to Hugging Face!\")\n\n# Load MedGemma for TEXT-ONLY clinical reasoning\nfrom transformers import AutoTokenizer, AutoModelForCausalLM\nimport torch\n\nprint(\"Loading MedGemma 1.5 4B...\")\n\nmodel_id = \"google/medgemma-1.5-4b-it\"\n\ntokenizer = AutoTokenizer.from_pretrained(model_id, token=hf_token)\nmodel = AutoModelForCausalLM.from_pretrained(\n    model_id,\n    token=hf_token,\n    torch_dtype=torch.bfloat16,\n    device_map=\"auto\"\n)\n\nprint(\"‚úÖ MedGemma loaded successfully!\")# Install required packages\n!pip install -q transformers accelerate\n\n# Login to Hugging Face using Kaggle secrets\nfrom kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\n\ntry:\n    hf_token = user_secrets.get_secret(\"HF_TOKEN\")\n    print(\"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\")\nexcept:\n    print(\"‚ùå Could not get HF_TOKEN - check Secrets panel\")\n    raise\n\nfrom huggingface_hub import login\nlogin(token=hf_token)\n\nprint(\"‚úÖ Logged in to Hugging Face!\")\n\n# Load MedGemma for TEXT-ONLY clinical reasoning\nfrom transformers import AutoTokenizer, AutoModelForCausalLM\nimport torch\n\nprint(\"Loading MedGemma 1.5 4B...\")\n\nmodel_id = \"google/medgemma-1.5-4b-it\"\n\ntokenizer = AutoTokenizer.from_pretrained(model_id, token=hf_token)\nmodel = AutoModelForCausalLM.from_pretrained(\n    model_id,\n    token=hf_token,\n    torch_dtype=torch.bfloat16,\n    device_map=\"auto\"\n)\n\nprint(\"‚úÖ MedGemma loaded successfully!\")# Install required packages\n!pip install -q transformers accelerate\n\n# Login to Hugging Face using Kaggle secrets\nfrom kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\n\ntry:\n    hf_token = user_secrets.get_secret(\"HF_TOKEN\")\n    print(\"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\")\nexcept:\n    print(\"‚ùå Could not get HF_TOKEN - check Secrets panel\")\n    raise\n\nfrom huggingface_hub import login\nlogin(token=hf_token)\n\nprint(\"‚úÖ Logged in to Hugging Face!\")\n\n# Load MedGemma for TEXT-ONLY clinical reasoning\nfrom transformers import AutoTokenizer, AutoModelForCausalLM\nimport torch\n\nprint(\"Loading MedGemma 1.5 4B...\")\n\nmodel_id = \"google/medgemma-1.5-4b-it\"\n\ntokenizer = AutoTokenizer.from_pretrained(model_id, token=hf_token)\nmodel = AutoModelForCausalLM.from_pretrained(\n    model_id,\n    token=hf_token,\n    torch_dtype=torch.bfloat16,\n    device_map=\"auto\"\n)\n\nprint(\"‚úÖ MedGemma loaded successfully!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2026-02-23T09:17:30.565994Z","iopub.execute_input":"2026-02-23T09:17:30.566603Z","iopub.status.idle":"2026-02-23T09:19:16.527252Z","shell.execute_reply.started":"2026-02-23T09:17:30.566575Z","shell.execute_reply":"2026-02-23T09:19:16.526446Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Retrieved HF_TOKEN from Kaggle secrets\n‚úÖ Logged in to Hugging Face!\nLoading MedGemma 1.5 4B...\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"config.json:   0%|          | 0.00/2.55k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"9f0b48ae062f4ff5b2e446f1f3afbdd7"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"tokenizer_config.json:   0%|          | 0.00/1.16M [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"babf31ce1d8d4ed58c5964fe8d9cb6ce"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"tokenizer.json:   0%|          | 0.00/33.4M [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"ebd61516982a46d6842b0fb88b133396"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"added_tokens.json:   0%|          | 0.00/35.0 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"d5dd876609c94e3b880b7e3f649a0fc0"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"special_tokens_map.json:   0%|          | 0.00/662 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"855978ce54b94177a2505c582acf124b"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"chat_template.jinja:   0%|          | 0.00/1.53k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"2520e8f4364344f78ed715cf5aa77922"}},"metadata":{}},{"name":"stderr","text":"`torch_dtype` is deprecated! Use `dtype` instead!\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"model.safetensors.index.json:   0%|          | 0.00/90.6k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"5a5e0d79831643ceafa8100f9ef66a83"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"Downloading (incomplete total...): 0.00B [00:00, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"83169a224626418eb113465f3278ea1c"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"Fetching 2 files:   0%|          | 0/2 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"362b672f34c24f3fa18d27855267a0ad"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"Loading weights:   0%|          | 0/883 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"b87bb0ee6bb34c1092afeffd465398ee"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"generation_config.json:   0%|          | 0.00/115 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"f184588f0e684fbcaf67ee768094872e"}},"metadata":{}},{"name":"stdout","text":"‚úÖ MedGemma loaded successfully!\n‚úÖ Retrieved HF_TOKEN from Kaggle secrets\n‚úÖ Logged in to Hugging Face!\nLoading MedGemma 1.5 4B...\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"Loading weights:   0%|          | 0/883 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"5c9069dd2d0d404991171f8aaeaf73b3"}},"metadata":{}},{"name":"stdout","text":"‚úÖ MedGemma loaded successfully!\n‚úÖ Retrieved HF_TOKEN from Kaggle secrets\n‚úÖ Logged in to Hugging Face!\nLoading MedGemma 1.5 4B...\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"Loading weights:   0%|          | 0/883 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"f7561de2dd384edda0ba2bd0f4537901"}},"metadata":{}},{"name":"stdout","text":"‚úÖ MedGemma loaded successfully!\n‚úÖ Retrieved HF_TOKEN from Kaggle secrets\n‚úÖ Logged in to Hugging Face!\nLoading MedGemma 1.5 4B...\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"Loading weights:   0%|          | 0/883 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"db78eb266d0a42799a7d3307b05744c0"}},"metadata":{}},{"name":"stdout","text":"‚úÖ MedGemma loaded successfully!\n‚úÖ Retrieved HF_TOKEN from Kaggle secrets\n‚úÖ Logged in to Hugging Face!\nLoading MedGemma 1.5 4B...\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"Loading weights:   0%|          | 0/883 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"9b3f945942c142738d9ccd226747c4af"}},"metadata":{}},{"name":"stdout","text":"‚úÖ MedGemma loaded successfully!\n","output_type":"stream"}],"execution_count":4},{"cell_type":"code","source":"# Clear GPU memory\nimport torch\ntorch.cuda.empty_cache()\nimport gc\ngc.collect()\n# Test with clinical reasoning prompt\nprompt = \"\"\"You are a nuclear medicine physician expert in Lu-177 PSMA radioligand therapy.\n\nPATIENT DATA:\n- Kidney absorbed dose (Ga-68 scan): 12.5 Gy\n- Predicted Lu-177 kidney dose: 18.3 Gy\n- eGFR: 45 mL/min/1.73m¬≤\n- Prior kidney disease: Stage 3a CKD\n\nQUESTION: Is this patient eligible for Lu-177 PSMA therapy according to EANM guidelines?\n\nProvide structured response:\n1. Eligibility (Yes/No/With modifications)\n2. Key considerations\n3. Dose recommendations\n4. Monitoring requirements\"\"\"\n\ninputs = tokenizer(prompt, return_tensors=\"pt\").to(model.device)\n\nprint(\"\\n\" + \"=\"*70)\nprint(\"GENERATING MEDGEMMA CLINICAL RECOMMENDATION...\")\nprint(\"=\"*70)\n\noutputs = model.generate(\n    **inputs,\n    max_new_tokens=500,\n    temperature=0.7,\n    do_sample=True\n)\n\nresponse = tokenizer.decode(outputs[0], skip_special_tokens=True)\n\nprint(\"\\n\" + \"=\"*70)\nprint(\"MEDGEMMA RESPONSE:\")\nprint(\"=\"*70)\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2026-02-23T09:19:16.528968Z","iopub.execute_input":"2026-02-23T09:19:16.529394Z","iopub.status.idle":"2026-02-23T09:19:55.425519Z","shell.execute_reply.started":"2026-02-23T09:19:16.529367Z","shell.execute_reply":"2026-02-23T09:19:55.424753Z"}},"outputs":[{"name":"stderr","text":"Setting `pad_token_id` to `eos_token_id`:1 for open-end generation.\n","output_type":"stream"},{"name":"stdout","text":"\n======================================================================\nGENERATING MEDGEMMA CLINICAL RECOMMENDATION...\n======================================================================\n\n======================================================================\nMEDGEMMA RESPONSE:\n======================================================================\nYou are a nuclear medicine physician expert in Lu-177 PSMA radioligand therapy.\n\nPATIENT DATA:\n- Kidney absorbed dose (Ga-68 scan): 12.5 Gy\n- Predicted Lu-177 kidney dose: 18.3 Gy\n- eGFR: 45 mL/min/1.73m¬≤\n- Prior kidney disease: Stage 3a CKD\n\nQUESTION: Is this patient eligible for Lu-177 PSMA therapy according to EANM guidelines?\n\nProvide structured response:\n1. Eligibility (Yes/No/With modifications)\n2. Key considerations\n3. Dose recommendations\n4. Monitoring requirements\n5. Contraindications/Precautions\n\nLet's break down the considerations for each section:\n\n1.  **Eligibility:**\n    *   **Core Criteria:** The patient has a documented prostate cancer diagnosis and is being considered for Lu-177 PSMA therapy. This is the fundamental requirement.\n    *   **Kidney Function:** The patient has a CKD stage 3a (eGFR 45 mL/min/1.73m¬≤). This is a critical factor.\n    *   **Comparison:** Compare the predicted Lu-177 kidney dose (18.3 Gy) to the EANM guideline threshold for kidney dose in patients with CKD. The threshold is generally considered to be 15 Gy for CKD stage 3 and higher.\n    *   **Conclusion:** Since the predicted Lu-177 kidney dose (18.3 Gy) exceeds the EANM guideline threshold (15 Gy) for patients with CKD stage 3a, the patient is **not** eligible for standard Lu-177 PSMA therapy.\n\n2.  **Key Considerations:**\n    *   **Kidney Dose:** The primary concern is the predicted Lu-177 kidney dose. The EANM guidelines explicitly state that Lu-177 PSMA therapy should not be administered to patients with CKD stage 3a or worse (eGFR < 60 mL/min/1.73m¬≤) due to the significantly increased risk of acute kidney injury (AKI).\n    *   **Patient's CKD Stage:** The patient's eGFR of 45 mL/min/1.73m¬≤ falls into CKD stage 3a, which is precisely the category excluded by the guidelines.\n    *   **Risk vs. Benefit:** While the risk of AKI is high, the potential benefit of Lu-177 PSMA therapy for prostate cancer in this specific patient might be considered, *but only* after extensive discussion with the patient regarding the risks and potential benefits, and potentially after consultation with a nephrologist. The EANM guidelines emphasize this limitation.\n    *   **Alternative Therapies:** Consider alternative therapeutic options for this patient, such as external beam radiotherapy (EBRT), androgen deprivation therapy (ADT), or potentially other radioligand therapies (e.g., Ga-68 PSMA\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"import torch\n\nprint(\"GPU Available:\", torch.cuda.is_available())\nprint(\"GPU Name:\", torch.cuda.get_device_name(0))\nprint(\"Total GPU Memory:\", torch.cuda.get_device_properties(0).total_memory / 1e9, \"GB\")\nprint(\"Allocated:\", torch.cuda.memory_allocated(0) / 1e9, \"GB\")\nprint(\"Reserved:\", torch.cuda.memory_reserved(0) / 1e9, \"GB\")\nprint(\"Free:\", (torch.cuda.get_device_properties(0).total_memory - torch.cuda.memory_allocated(0)) / 1e9, \"GB\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2026-02-23T09:19:55.426522Z","iopub.execute_input":"2026-02-23T09:19:55.426845Z","iopub.status.idle":"2026-02-23T09:19:55.432922Z","shell.execute_reply.started":"2026-02-23T09:19:55.426809Z","shell.execute_reply":"2026-02-23T09:19:55.432221Z"}},"outputs":[{"name":"stdout","text":"GPU Available: True\nGPU Name: Tesla T4\nTotal GPU Memory: 15.637086208 GB\nAllocated: 8.608854016 GB\nReserved: 15.449718784 GB\nFree: 7.028232192 GB\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"# Clear GPU memory before next case\ntorch.cuda.empty_cache()\ngc.collect()\n\nprint(\"\\n\" + \"=\"*70)\nprint(\"CASE 3: HIGH RISK\")\nprint(\"=\"*70)\n\nprompt_case3 = \"\"\"You are a nuclear medicine physician expert in Lu-177 PSMA radioligand therapy.\n\nPATIENT DATA:\n- Kidney absorbed dose (Ga-68 scan): 20.0 Gy\n- Predicted Lu-177 kidney dose: 29.4 Gy\n- eGFR: 35 mL/min/1.73m¬≤\n- Prior kidney disease: Stage 3b CKD\n\nQUESTION: Is this patient eligible for Lu-177 PSMA therapy according to EANM guidelines?\n\nProvide structured response:\n1. Eligibility (Yes/No/With modifications)\n2. Key considerations\n3. Dose recommendations\n4. Monitoring requirements\"\"\"\n\ninputs = tokenizer(prompt_case3, return_tensors=\"pt\").to(model.device)\n\noutputs = model.generate(\n    **inputs,\n    max_new_tokens=500,\n    temperature=0.7,\n    do_sample=True\n)\n\nresponse = tokenizer.decode(outputs[0], skip_special_tokens=True)\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2026-02-23T09:20:33.735009Z","iopub.execute_input":"2026-02-23T09:20:33.735225Z","iopub.status.idle":"2026-02-23T09:21:11.731881Z","shell.execute_reply.started":"2026-02-23T09:20:33.735204Z","shell.execute_reply":"2026-02-23T09:21:11.731187Z"}},"outputs":[{"name":"stderr","text":"Setting `pad_token_id` to `eos_token_id`:1 for open-end generation.\n","output_type":"stream"},{"name":"stdout","text":"\n======================================================================\nCASE 3: HIGH RISK\n======================================================================\nYou are a nuclear medicine physician expert in Lu-177 PSMA radioligand therapy.\n\nPATIENT DATA:\n- Kidney absorbed dose (Ga-68 scan): 20.0 Gy\n- Predicted Lu-177 kidney dose: 29.4 Gy\n- eGFR: 35 mL/min/1.73m¬≤\n- Prior kidney disease: Stage 3b CKD\n\nQUESTION: Is this patient eligible for Lu-177 PSMA therapy according to EANM guidelines?\n\nProvide structured response:\n1. Eligibility (Yes/No/With modifications)\n2. Key considerations\n3. Dose recommendations\n4. Monitoring requirements\n\n---\n\n**1. Eligibility:**\n\nNo, this patient is **not** eligible for Lu-177 PSMA therapy according to EANM guidelines.\n\n**Reasoning:**\n\n*   **Kidney Function:** The patient's estimated Glomerular Filtration Rate (eGFR) is 35 mL/min/1.73m¬≤.\n*   **EANM Guideline Threshold:** The EANM guidelines state that Lu-177 PSMA therapy is contraindicated in patients with a predicted Lu-177 kidney dose (Ki-PSMA) exceeding 20 Gy.\n*   **Calculated Dose:** The predicted Lu-177 kidney dose is 29.4 Gy, which is above the guideline threshold of 20 Gy.\n*   **Prior Kidney Disease:** The patient already has pre-existing Stage 3b Chronic Kidney Disease (CKD), which further increases the risk associated with radiation exposure to the kidneys.\n\n**2. Key Considerations:**\n\n*   **High Risk:** The patient has both impaired kidney function (eGFR 35) and a predicted high radiation dose (29.4 Gy) to the kidneys. This combination places them in a high-risk category for severe acute kidney injury (AKI) and long-term kidney damage following Lu-177 PSMA therapy.\n*   **Risk Mitigation (If considered despite guidelines):** While the guidelines are clear, in cases of extreme clinical urgency where the benefits are deemed substantial and risks are meticulously discussed (often outside standard protocol), modifications *might* be considered, but this is **not** standard practice and carries significant risks. In this specific scenario, the risk likely outweighs any potential benefit.\n*   **Alternative Treatment:** Given the contraindication, alternative treatment options for metastatic castration-sensitive prostate cancer (mCSPC) should be strongly considered.\n\n**3. Dose Recommendations:**\n\n*   **Contraindicated:** Lu-177 PSMA therapy is contraindicated in this patient due to the predicted Ki-PSMA exceeding 20 Gy.\n\n**4. Monitoring Requirements:**\n\n*   **Pre-treatment:** Thorough assessment of renal function (eGFR, creatinine, BUN, urinalysis, possibly renal ultrasound) is mandatory.\n*   **During Treatment:** Close monitoring of renal function (eGFR, creatinine) is required before, during, and after the administration of Lu-1\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"","metadata":{"trusted":true},"outputs":[],"execution_count":null}]}